Bangalee, A, S Hanley, and V Bangalee. 2022. “MEDICINE AND THE LAW: Dolutegravir As First-Line Antiretroviral Therapy in South Africa: Beware the One-Size-Fits-All Approach”. South African Medical Journal 112 (10): 787-90. https://doi.org/10.7196/SAMJ.2022.v112i10.16596.